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An attempt to assess the “utility” of directional 
atherectomy was made using a new quantitative 
anglographic index. This index can be subdivided 
into an initial gafn component and a restenosis 
component. The initial gain index is the ratio be- 
tween the gain in diameter during intervention 
and the theoreticaify achievable gafn (i.e., refer- 
ence diameter). The restenosis index is the ratio 
between the decrease at follow-up and the initial 
gain during the procedure. The net result at 
long-term fofiow-up is characterized by the utiii- 
ty index, which is the ratio between the final 
gain in diameter at follow-up and what theoreti- 
cally could have been achieved. Far this purpose, 
30 coronary artery lesions were selected from a 
consecutive series of successfully dilated primary 
angiopiasty lesions and were matched with the 
initial 30 successfuiiy treated primary atherec- 
tomy lesions. Matching by location of stenosis 
and reference diameter resulted in 2 comparable 
groups with identical preprocedurai stenosis 
characteristics. Atherectomy resulted in an in- 
crease in minimal iuminai diameter 2 times iarg- 
er than angiopiasty (1.53 vs 0.77 mm; p 
<O.OOOl). However, at follow-up there was a 
significant decrease in minimal iuminai diameter 
and a significant increase in percent diameter 
stenosis in the groups with atherectomy and an- 
giopiasty (1.69 f 0.66 vs 1.57 f 0.66 mm, 
p = not significant [NS], and 37 f 18 vs 47 f 
lS%, p = NS, respectively). The decrease in min- 
imal iuminai gain was more pronounced in the 
group with atherectomy than in that with angio- 
piasty (0.92 f 0.69 vs 0.35 f 0.51 mm; 
p = 0.0005). Consequently, direetionai atherec- 
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tomy resulted in a significantly higher initial gain 
ratio than did balloon angiopiasty (0.64 vs 0.41, 
p <O.OOOOl). At follow-up, restenosis and utility 
ratios were comparabfe in both groups (0.56 vs 
0.62, p = NS, and 0.29 vs 0.23, p = NS, respec- 
tively). in matched groups, directional atherec- 
tomy is a very effective device wfth a substan- 
tiaify better initial result than that with balloon 
angiopiasty. However, it appears to be a potent 
stimulator of the restenosis process, because at 
follow-up this initial favorable resuft is lost, and 
the minimal iuminai diameter is comparable to 
that after balloon angiopiasty. Thus, the final 
utility of directional coronary atherectomy is not 
significantly different from that of conventional 
balloon angiopfasty. 
(Am J Cardioi 1991;68:1566-1563) 
R 
estenosis after conventional balloon angioplasty 
remains the major limitation of this proce- 
dure.l-5 Despite extensive fforts to elucidate 
this phenomenon, our knowledge remains incomplete. 
In recent years studies have suggested that intimal hy- 
perplasia is the major mechanism responsible for reste- 
no&F9 and that lesion characteristics and regional flow 
dynamics influence this proliferative process. loBecause 
improved operator experience and angioplasty tech- 
niques have not caused a reduction in restenosis rates, 
interventional cardiologists have designed new devices 
aimed at debulking instead of dilating atherosclerotic 
plaque. Directional atherectomy is a new technique 
with the potential advantage of creating smooth lumi- 
nal surface. However, early experience with atherec- 
tomy indicates that restenosis rates are comparable 
with those after conventional balloon angioplasty, al- 
though a randomized study has not been initiated11-13 
Recently it has been demonstrated that the immediate 
results of atherectomy are superior to those achieved by 
balloon angioplasty14; whether this initial advantage 
can be maintained uring follow-up and may ultimate- 
ly result in a reduction of the restenosis rate needs to be 
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assessed. Therefore, the present study was performed to 
determine whether this initial favorable result obtained 
with athercctomy affects the incidence of restenosis. 
METHODS 
Patient group: From September 1989 through Jan- 
uary 199 1, 66 patients underwent 74 atherectomy pro- 
cedures. For the purpose of this study, the initial 30 
consecutive patients (23 men and 7 women, mean age 
f standard deviation 60.2 f 10.1) who underwent an 
angiographically successful procedure (postprocedural 
diameter stenosis <50%, with tissue retrieval) of a pri- 
mary lesion in a native coronary artery were selected. 
At the time of atherectomy, 16 patients were in New 
York Heart Association functional class IV, 7 in III 
and 7 in II. Coronary angiography showed l-vessel dis- 
ease in 25 patients, 2-vessel disease in 4 and 3-vessel 
disease in 1. The site of obstruction was located in the 
left anterior descending coronary artery in 18 patients, 
the right coronary artery in 7 and the circumflex ar- 
tery in 5. 
Atherestmy procedure: After administration of lo- 
cal anesthesia, n 11Fr sheath was inserted in the fem- 
oral artery. All patients received 250 mg of acetylsali- 
cylic acid and 10,000 U of heparin intravenously. Intra- 
coronary injection of isosorbide dinitrate was performed 
to optimally vasodilate the vessel. After initial angio- 
grams in multiple views were obtained, a special 11Fr 
guiding catheter was placed into the ostium of the coro- 
nary artery. Under fluoroscopy, the guidewire was ad- 
vanced in the distal part of the artery. Then, the ather- 
ectomy device was directed over the guidewire and po- 
sitioned across the stenosis. The support balloon was 
then inflated up to 0.5 atm, the cutter was retracted 
and balloon inflation pressure was increased to 2 to 3 
atm. The driving motor was activated, and the rotating 
cutter was slowly advanced to cut and collect the pro- 
truding atherosclerotic lesion in the collecting chamber 
located at the tip of the catheter. After every pass, the 
balloon was deflated and either removed or reposi- 
tioned. On average, 6.7 f 2.9 passes in multiple direc- 
tions were performed across a stenosis. Atherectomy 
was considered successful when the residual stenosis 
was <50% after tissue retrieval. After atherectomy, the 
arterial and venous sheaths were usually left in place 
for 6 hours. Patients were monitored for 24 hours, and 
electrocardiograms and cardiac enzyme levels were ob- 
tained twice daily. Nifedipine was administered every 2 
hours for 24 hours after the procedure, and the patients 
were administered aspirin for 1 year. 
Follow-up evaluation: After successful atherectomy 
or angioplasty (i.e., <50% postprocedural diameter ste- 
nosis on visual inspection), patients were examined at 
the outpatient clinic, The follow-up coronary angio- 
gram was obtained within 2 weeks after an exercise 
test. Angiography was performed earlier if symptoms 
occurred within 6 months. 
Quantitative coronary angiography: Quantitative 
analysis of the coronary segments was performed with 
the computer-based Coronary Angiography Analysis 
System (CAAS), previously described in detail.4~5~15~16 
In essence, boundaries of a selected coronary artery 
segment were detected automatically from optically 
magnified and video-digit&d regions of interest (5 12 
X 5 12 pixels) of a cineframe. The absolute diameter of 
the stenosis in millimeters was determined using the 
guiding catheter as a scaling device. Each individual 
catheter was measured with a micrometer and used as 
a scaling device. Correction for pincushion distortion 
was performed. The computer-estimation f the origi- 
nal dimension of the artery at the site of the obstruction 
was used to define the interpolated reference diameter. 
The percentage diameter and area stenosis, as well as 
the cross-sectional rea (mm*), were then calculated. 
INTERPOLATED REFERENCE DIAMETER (RD) 
EXTENT OF OBSTRUCTION 
DlAMETER F”NCT,ON 
FIGURE 1. Graphic ihistratkm ef stenesis perameters ebtabd by qmntitative wronary analysis. Left, y axis ropmsents rofer- 
enee~,~v~kngthis~~akngxaxis.Rekrence~eramlleaionkngtharedeterminedbydiamet~ 
at bounderieg et leskn that are ddined by curvature anatysis. Ri&t, am&me analysis is desdbed. Curvalure is defined by 
rateofchangeofangleLrough~tangentofwne~urns,amlwhichfwacirdeiseqwltoreciprocalofradius(R). 
MLD = minimal hentnal &meter. 
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The length of the lesion (mm) was determined from the 
diameter function on the basis of curvature analysis 
(Figure 1). Symmetry was defined as the coefficient of 
the left-hand distance between the reconstructed inter- 
polated reference diameter and actual vessel contours, 
and the right-hand distance between the reconstructed 
and actual contours at the site of the obstruction. Sym- 
metry index ranged from 0 (totally eccentric stenosis) 
to 1 (symmetric). The degree of coronary bend was 
assessed by the curvature value at the obstruction site. 
This parameter was computed as the average value of 
all individual curvature values along the centerline of 
the coronary segment, with curvature defined as the 
first derivative of the tangent as it moves along the cen- 
terline, which for a circle is equal to the reciprocal of 
the radius. The area between the actual and recon- 
structed contours at the obstruction site was defined as 
the area plaque (expressed in mm2). To standardize the 
method of analysis of the interventional and follow-up 
angiograms, the following measures were taken? First, 
the x-ray system was exactly positioned, as was noted 
at the time of the intervention. Second, all study frames 
to be analyzed were selected at enddiastole to mini- 
mize foreshortening. Third, the investigator-determined 
beginning and end point of a segment of a major coro- 
nary artery were identified according to the defmitions 
of the American Heart Association.17 Finally, Polaroid 
photographs were taken of the video image with the 
detected contours uperimposed toensure that the anal- 
ysis was performed on the same coronary segments in 
consecutive angiograms. Patients with balloon angio- 
plasty were enrolled in ongoing restenosis trials, and 
therefore, according to the protocol, systematically re- 
ceived intracoronary nitroglycerin before and after an- 
gioplasty, and during follow-up catheterization, where- 
(mm) 
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FIGURE 2. Graphii illustration of principle of initial gain, re- 
stsnosis and utility indexes. Initial gain index is represented 
by the ratio B/A, restenosis index by C/B, and utility index by 
D/A. A = maximal achievable increase in minimal hninal di- 
ameter(MLD);B=gaTninMU)dwingprocedure;C=reduc- 
tionduringfoUow-up;D=long-iefmresun;RD=referewdi- 
ameter. 
as patients with atherectomy were less frequently ad- 
ministered intracoronary nitroglycerin at recatheteri- 
zation. 
Restenosis: Two different criteria were used to de- 
fme the restenosis rate. We have found a change in 
minimal lumen diameter 10.72 mm to be a reliable 
indicator of angiographic progression of vessel narrow- 
ing.4J5J6 This value takes into account he limitations 
of coronary angiographic measurements and represents 
the long-term variability for repeat measurements of a 
coronary stenosis using CAAS. The second criterion for 
restenosis chosen was an increase in the diameter steno- 
sis from GO% after intervention to 50% at follow- 
up. This criterion was selected because clinical practice 
continues to assess lesion severity by percent stenosis. 
Assessment of initial gain, restanosis and utility ra- 
tio: To compare the relative efficacy of various inter- 
ventional techniques, it is critical to relate the procedur- 
al outcome and changes during follow-up to the maxi- 
mal achievable result. Therefore we propose the use of 
the aforementioned ratios in the evaluation of intracor- 
onary interventions. Briefly, quantitative angiographic 
changes after intracoronary intervention may be divid- 
ed in 3 stages (Figure 2). The first or “operational 
stage,” is characterized by the interaction of the opera- 
tional device with the lesion. In becoming operational, 
the diameter of the device may expand (directional ath- 
erectomy, balloon, stent) or maintain its original di- 
mensions (laser, transluminal extraction catheter, rota- 
tional ablation). During this stage, the maximal effect 
of the device is achieved and determines to what extent 
the minimal luminal diameter may be increased. The 
initial gain index represents the ratio between the 
achieved luminal and maximal achievable luminal im- 
provements (reference diameter minus minimal lumen 
diameter (MLD) before intervention), and is described 
by the following equation: initial gain index: change in 
MLD at intervention/reference diameter - MLD be- 
fore intervention. The initial gain index ranges from 0 
(no effect) to 1 (no residual stenosis). The second stage 
or “restenosis stage” begins during follow-up when bio- 
logical processes determine the extent of intimal hyper- 
plasia ultimately leading to a loss of luminal gain. 
The restenosis ndex represents he ratio of decrease 
in luminal diameter improvement during follow-up and 
the achieved changes induced by intracoronary inter- 
vention, and is described by the following equation: re- 
stenosis index: MLD after intervention - MLD follow- 
up/change in MLD at intervention. The restenosis n- 
dex ranges from 0 (initial benefit intact) to 1 (initial 
benefit completely lost). 
The utility index represents he ratio of the net gain 
in lumen improvement at follow-up and the maximal 
achievable luminal improvement, and is described by 
the following equation: utility index: change in MLD at 
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intervention - change in MLD at follow-up/reference 
diameter - MLD before intervention. The utility index 
ranges from 0 (no utility) to 1 (perfect result). 
Matching process: The coronary artery tree was 
subdivided in 15 segments according to American 
Heart Association guidelines,1s and the lesions were in- 
dividually matched according to stenosis location and 
reference diameter. The principles of matching are 
threefold: the angiographic dimensions of matched le- 
sions are assumed to be “identical,” the observed iffer- 
ence between the 2 “identical” lesions must be within 
the range of CAAS reproducibility of 0.1 mm (1 stan- 
dard deviation),5 and finally, the reference diameters of 
the matched vessels are selected within a range of f 
0.3 mm (3 standard eviations; 99% confidence limits). 
To assess the immediate result of atherectomy and bal- 
loon angioplasty, 30 coronary artery lesions were select- 
ed by an independent technician (EMvS) from a con- 
secutive series of successfully dilated balloon angio- 
plasty lesions while complying with the selection criteria 
of matching. At the time of selection, the investigators 
were unaware of the 6-month angiographic outcome of 
these lesions. Matching was considered adequate if the 
mean difference of the reference diameter between 
the groups equaled 0 with standard deviation <0.3 
mm.i9 Currently, the Thoraxcenter angiographic data- 
base contains quantitatively assessed stenosis data for 
2,300 patients treated with either angioplasty (n = 
1847) intracoronary stenting (n = 406), or directional 
or rotational atherectomy (n = 120). 
Statistical analysis: All values are expressed as 
mean f 1 standard deviation. Comparisons of the se- 
verity of minimal luminal diameter, area plaque, dia- 
meter stenosis, curvature value symmetry index and 
length between the groups were performed using anal- 
ysis of variance and the unpaired Student’s t test. 
Differences were considered statistically significant at 
p <0.05. 
RESULTS 
Preprocedural stenosis characteristics of the 
matched patients are listed in Table I. Matching for 
stenosis location and reference diameter resulted in 
groups of patient with comparable severity of lesions. 
Matching was considered adequate because the refer- 
ence diameter was equal in both groups (3.03 f 0.57 vs 
3.07 f 0.55 mm; p = not significant), whereas the 
mean difference for this parameter between the groups 
was 0.0 mm (standard deviation 0.2 mm). Preproce- 
dural minimal luminal diameter in the groups with ath- 
erectomy and angioplasty were 1.08 f 0.37 and 1.15 f 
0.36 mm, respectively. The other stenosis parameters 
(diameter stenosis, area plaque, symmetry index and 
length) did not differ signilicantly, with the sole excep- 
tion of curvature value, which was lower in the group 
TABLE I Matched Preprocedural Stenosis Characteristics of 30 
Patients with Successful Coronary Atherectomy Compared with 
Successful Balloon Angioplasty 
Reference diameter (mm) 
Minimal luminal diameter 
(mm) 
Diameter stenosis (%) 
Area plaque (mm2) 
Curvaturevalue 
Symmetry index 
Length 
*p <o.oz. 
Before 
Atherectomy 
3.03 2 0.57 
1.08 + 0.37 
64 f 10 
9.5 r 6.4 
15.9 f 7.0 
0.6 f 0.2 
6.8 + 2.7 
Before 
Angioplasty 
3.07 f 0.55 
1.15 f 0.36 
63 -+ 8 
8.4 -+ 3.6 
22.2 * 13.1* 
0.5 rf: 0.3 
6.5 2 2.6 
TABLE II Quantitative Comparison of the Immediate and 
Long-Term Results of Atherectomy and Balloon Angioplasty 
67 = 30) 
Unpaired 
Atherectomy Angioplasty t Test 
Reference diameter 
(mm) 
Pre 3.03 r 0.57 3.07 IL 0.55 NS 
Post 3.24 f 0.32 3.09 f 0.56 NS 
Follow-up 2.81 f 0.57 3.04 +- 0.65 NS 
Minimal luminal 
diameter (mm) 
Pre 1.08 f 0.37 1.15 f 0.36 NS 
Post 2.61 f 0.33 1.92 f 0.31 0.0000 
Follow-up 1.69 f 0.58 1.57 r 0.58 NS 
Difference in minimal 
luminal diameter (mm) 
Post to pre 1.53 f 0.47 0.77 f 0.30 0.0000 
Post to follow-up 0.92 2 0.69 0.35 k 0.51 0.0005 
Diameter stenosis (%) 
Pre 64 2 10 63 + 8 NS 
Post 19 Ir 9 372 10 0.0000 
Follow-up 37-c 18 47 2 18 0.04 
Difference in diameter 
stenosis (%) 
Pre-post 45 k 12 26 + 12 0.0000 
Follow-up-post 18 -+ 17 10 -+ 17 NS 
NS = not significant; Post = after intervention; Pm = before intervention. 
with atherectomy than in that with angioplasty (15.9 f 
7.0 vs 22.2 f 13.1; p <0.02). 
The immediate fficacy of atherectomy and angio- 
plasty as assessed by quantitative angiography is shown 
in Table II and Figure 3. As expected, both atherec- 
tomy and balloon angioplasty significantly improved 
minimal luminal diameter (1.08 f 0.37 to 2.61 f 0.33 
mm [p <O.OOOl], and 1.15 f 0.36 to 1.92 f 0.31 mm 
lp <O.OOl], respectively), but the increase in minimal 
luminal diameter was superior in the group with ather- 
ectomy than in that with angioplasty (1.53 vs 0.77 mm; 
p <O.OOOl). Accordingly, the initial gain ratio of ather- 
ectomy was also superior when compared with that of 
angioplasty (0.84 f 0.36 vs 0.41 f 0.18; p <O.OOOOl). 
Thus, percent diameter stenosis was reduced from 64 f 
10 to 19 f 9% (p <O.OOOl) in the group with atherec- 
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TABLE III Quantitative Assessment of Initial Gain, Restenosis 
and Utility Ratios After Atherectomy and Balloon Angioplasty 
(n = 30) 
Unpaired 
Atherectomy Angioplasty t Test 
Initial gain ratio 0.84 f 0.36 0.41 -c 0.18 0.0000 
Restenosis ratio 0.56 f 0.55 0.62 + 1.10 NS 
Utility ratio 0.29 f 0.33 0.23 k 0.28 NS 
NS = not significant. 
tomy, and from 63 f 8 to 37 f 10% (p <O.OOl) in the 
that with angioplasty. 
At follow-up, all patients with atherectomy and an- 
gioplasty included in this study underwent 6-month 
control catheterization. Angiographic follow-up in the 
groups with atherectomy and angioplasty were 95 and 
92%, respectively. Angiographic analysis at follow-up 
(Table II and Figure 4) showed a decrease in minimal 
luminal diameter in both groups (2.61 f 0.33 to 1.69 
f 0.58 mm with atherectomy, 1.92 f 0.31 to 1.57 f 
0.58 mm with angioplasty). Thus, the loss in minimal 
luminal diameter was more pronounced in the group 
with atherectomy than in that with angioplasty (0.92 f 
0.69 vs 0.35 f 0.51 mm; p <O.OOOS). Accordingly, 
percent diameter stenosis increased from 19 f 9 to 37 
f 18% in the group with atherectomy, and from 37 f 
10 to 47 f 18% in that with angioplasty. The concomi- 
tant restenosis and utility ratios are listed in Table III. 
Percent restenosis (detectable hyperplasia by quantita- 
tive coronary analysis) according to the 0.72 mm de- 
crease in minimal luminal diameter (2 times the stan- 
dard deviation of the long-term variability of the mini- 
(N=30 LESIONS) 
,.--- 
/ 
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FlGURE 3. Cwnulative freqwncy of im- 
mediate resulis of directional atherectomy 
(DCA) and balloon angioplasty (PTCA) in 
39 matched lesions. DirectMal atherec- 
tomy resulted in an increase in minimal lu- 
minal diameter (MLD) from 1.66 to 2.61 
mm, whereas angbplasty induced an in- 
crease from 1.15 to 1.92 mm. Post = 
after intervention; Pre = before interven- 
tlon. 
FIGURE 4. Cumulative freqwncy of long 
tefmresultsofdirectionalaMrectomy 
and angioplasty in this matchsd pop&- 
6011. At G-month follow-up (Fup), initial 
favorabls resutt ot athwectomy is lost 
compared with that of balloon angioplasty. 
DtherahbrevlatllaslnFlgve3. 
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ma1 luminal diameter measurements u ing CAAS cri- 
terion) was 60% in the group with atherectomy versus 
36% in that with angioplasty. When restenosis is de- 
fined by an increase in diameter stenosis 250% at fol- 
low-up, the restenosis percentages are 20 vs 16% (ath- 
erectomy vs angioplasty). 
DISCUSSION 
Coronary angioplasty is now an accepted form of 
treatment for patients with coronary artery disease. In 
the past, exponential growth in angioplasty has partly 
been the result of an increase patients returning with 
restenosis. Despite extensive fforts to improve catheter 
equipment we are still unable to effectively reduce 
the rate of restenosis. Because no fundamental design 
changes in balloon or balloon-derived catheter tech- 
niques are emerging, debulking techniques, uch as di- 
rectional atherectomy, have been intrcxluced to improve 
the angioplastic process and to presumably reduce the 
rate of restenosis. The potential advantages of debulk- 
ing atheromatous tissue over remodeling plaque with 
balloon angioplasty include: minimizing smooth muscle 
cell injury by wall stress; eliminating smooth muscle 
cells and thereby reducing their proliferative potential; 
improving regional blood flow and rheology by induc- 
ing fewer fissures or dissections; reducing radial stretch 
forces, as applied with a dilating balloon; and creating 
larger increases in minimal luminal diameter. Indeed, 
recent studies have reported a larger increment in lumi- 
nal improvement after atherectomy than after conven- 
tional balloon angioplasty, l4whereas other investigators 
observed a low incidence of postprocedural dissec- 
tions 11,12,14 
Study design: Whether atherectomy is superior to 
balloon angioplasty can only be assessed by a random- 
ized study. This type. of study would take several years, 
during which continuing refinements and improvements 
of catheter systems would take place, rendering the 
comparison unreliable and open to criticism. Therefore, 
we proposed a matching technique based on stenosis 
location and reference diameter to compare the results 
of various intracoronary interventional techniques. At 
present, this technique may be the best surrogate for a 
randomized trial when one tries to compare the short- 
and long-term results of atherectomy with those of con- 
ventional angioplasty. Using our matching program we 
selected comparable stenotic lesions with respect to 
baseline characteristics (minimal luminal diameter, di- 
ameter stenosis, length, area plaque and symmetry in- 
dex) as assessed by quantitative angiography. This 
study group reflects the baseline stenosis characteristics 
in patients treated with atherectomy20 or balloon angio- 
plasty.4,21 
Immediate results: This study confirms previous re- 
ports of improved luminal gain after atherectomy com- 
pared with that after conventional ngioplasty. l4Ather- 
ectomy resulted in a twofold increase in minimal lumi- 
nal diameter (1.09 f 0.37 to 2.61 f 0.33 mm) 
compared with that with angioplasty (1.15 f 0.36 to 
1.92 f 0.31 mm). Accordingly, percent diameter ste- 
nosis decreased more dramatically after atherectomy 
than after angioplasty. This improvement in luminal 
gain with atherectomy may be due to 3 mechanisms. 
First, introduction of the bulky device itself causes a 
lumen enlargement due to the “Dotter” effect. Second, 
the subsequent inflation of the support balloon may 
lead to further enlargement by stretching of the vessel 
wall. Finally, excision of the plaque determines the final 
result. 
Restenosis: Recurrence of a stenosis after intracoro- 
nary intervention may be assessed by clinical symp- 
toms, stress testing or coronary angiography. Because 
symptoms and functional achievement at exercise test- 
ing have low predictive values in regard to restenosis, 
diagnosis of restenosis should be based on reproducible 
quantitative angiographic measurements u ing a com- 
puter-assisted technique with either automated edge de- 
tection or videodensitometry. Furthermore, the defini- 
tion of restenosis a matter of ongoing debate. It has 
been shown by our investigative group,4922 as well as by 
others3 that the determination of the severity of steno- 
sis using percent diameter stenosis does not reflect 
changes after angioplasty, because the adjacent part of 
the dilated vessel may also be involved in the restenosis 
process, or the reference diameter may be simulta- 
neously reduced. Therefore, we selected minimal lu- 
minal diameter as a parameter for the morphologic 
changes after atherectomy or angioplasty. Minimal lu- 
minal diameter at follow-up was 1.69 mm for the group 
with atherectomy compared with 1.57 mm for that 
with balloon angioplasty (p = not significant). These 
findings are similar to previously documented late fol- 
low-up studies of coronary balloon angioplasty (1.69 to 
1.82 mm)4 and stenting (1.68 mm).23 Using the 250% 
diameter stenosis criterion, the rates of restenosis after 
atherectomy and angioplasty were 20 and 16%, respec- 
tively. Previous studies on restenosis after primary coro- 
nary atherectomy reported an incidence of restenosis of 
20%’ 1,12 using the 250% criterion. Thus, during fol- 
low-up, the initial greater gain in luminal diameter af- 
ter atherectomy compared with that after balloon angi- 
oplasty is totally lost. At follow-up, the reduction in 
minimal luminal diameter was 0.92 mm after atherec- 
tomy compared with 0.35 mm after angioplasty (p = 
0.0005). Although minimal luminal diameter changed 
more dramatically in the group with atherectomy than 
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in that with angioplasty, both had equal restenosis 
(0.56 vs 0.62; p = not significant) and utility (0.29 vs 
0.23; p = not significant) ratios, indicating that the rel- 
ative changes are equal for both interventional tech- 
niques. 
Animal and atherectomy studies11-13y20 have dem- 
onstrated that librointimal hyperplasia may develop in 
coronary arteries previously treated by balloon angio- 
plasty or atherectomy. Pathologic findings have raised a 
theory that deeper vascular injury is associated with a 
greater intimal proliferation. Injury beyond the subinti- 
ma1 level has been shown to be associated with more 
extensive intimal proliferation.24 These data are sup- 
ported by Webster et al25 who found a greater smooth 
muscle proliferation after high-inflation pressure with 
the same balloon size when compared with that after 
low pressure. Furthermore, an initial follow-up study 
after atherectomy indicates that this process may be 
accelerated when deep vessel wall components such as 
media and adventitia re removed.13 Additionally, ath- 
erectomy may lead to profound disrupture of the vessel 
wall architecture.26 Finally, the introduction of the 
bulkier atherectomy device may potentially lead to a 
greater amount of vessel wall stretching compared with 
that with the smaller balloon catheter system. All these 
influences may account for the greater cellular prolifer- 
ation of the lesion treated by atherectomy. 
Study limitations: There are several imitations to 
this study. First, it is an uncontrolled, observational 
study limited to a subset of patients with successful cor- 
onary atherectomy or balloon angioplasty. This consec- 
utive series of patients were studied by investigators 
unaware of the late angiographic results. Although 
matching for angiographic variables is a promising 
technique to assess the efficacy of intracoronary inter- 
ventions, patient- and procedure-related variables are 
not included in the analysis. Second, lesion complexity 
was not incorporated in the analysis. This is usually de- 
fined qualitatively 27; however, an objective and quanti- 
tative description of stenosis morphology has recently 
been introduced.28 Further improvement in quantitative 
analysis may assess lesion morphology in a continuous 
scale fashion rather than assigning lesions to discrete 
categories. This type of analysis hould be incorporated 
in future trials studying the efficacy of various interven- 
tional techniques. Third, this study is based on early 
experiences with atherectomy. Careful patient selection, 
future design changes and improved operator experi- 
ence may further improve the immediate and long-term 
results. Thus, controlled clinical trials are needed in the 
future to determine the immediate angiographic results 
and long-term efficacy of these interventions, as well as 
the benefit, if any, to particular subgroups of patients. 
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These studies should also address the presumed time 
frame for restenosis after any particular intervention. 
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